BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8891902)

  • 1. Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
    Pompetti F; Rizzo P; Simon RM; Freidlin B; Mew DJ; Pass HI; Picci P; Levine AS; Carbone M
    J Cell Biochem; 1996 Oct; 63(1):37-50. PubMed ID: 8891902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression.
    Gamberi G; Benassi MS; Bohling T; Ragazzini P; Molendini L; Sollazzo MR; Pompetti F; Merli M; Magagnoli G; Balladelli A; Picci P
    Oncology; 1998; 55(6):556-63. PubMed ID: 9778623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic implications of MDM2, p53 and K-ras gene alterations in osteosarcomas: MDM2 amplification and p53 mutations found in progressive tumors.
    Yokoyama R; Schneider-Stock R; Radig K; Wex T; Roessner A
    Pathol Res Pract; 1998; 194(9):615-21. PubMed ID: 9793960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
    Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
    Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the c-myc proto-oncogene in human chondrosarcoma.
    Castresana JS; Barrios C; Gómez L; Kreicbergs A
    Diagn Mol Pathol; 1992 Dec; 1(4):235-8. PubMed ID: 1342971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of C-myc gene expression in giant-cell tumor of bone.
    Gamberi G; Benassi MS; Böhling T; Ragazzini P; Molendini L; Sollazzo MR; Merli M; Ferrari C; Magagnoli G; Bertoni F; Picci P
    J Orthop Res; 1998 Jan; 16(1):1-7. PubMed ID: 9565066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X; Gao L; Zhe X
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.
    Sugimoto KJ; Kawamata N; Sakajiri S; Oshimi K
    Jpn J Cancer Res; 2002 Nov; 93(11):1270-7. PubMed ID: 12460470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines.
    Isfort RJ; Cody DB; Lovell G; Doersen CJ
    Mol Carcinog; 1995 Nov; 14(3):170-8. PubMed ID: 7576109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
    Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma in blood relatives.
    Longhi A; Benassi MS; Molendini L; Macchiagodena M; Picci P; Bacci G
    Oncol Rep; 2001; 8(1):131-6. PubMed ID: 11115584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of c-fos expression in benign and malignant musculoskeletal lesions.
    Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA
    J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
    Kochevar DT; Kochevar J; Garrett L
    Cancer Lett; 1990 Sep; 53(2-3):213-22. PubMed ID: 2208081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas.
    Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S
    Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
    Chi YK; Shen Q; Wang JC; Zheng XZ; Hou L; Zhang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):363-8. PubMed ID: 18677381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alterations of retinoblastoma gene and its protein expression in aggressive bone tumors].
    Li Y; Qiu J
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):262-5. PubMed ID: 10374331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.